Journals | Policy | Permission

Journal of Clinical Medicine Research

Review

Volume 6, Number 3, June 2014, pages 157-161

Multidisciplinary Approach to Synchronous Prostate and Rectal Cancer: Current Experience and Future Challenges

Prostate and rectal cancers account for the most common pelvic malignancies in the male population and can present either synchronously or metachronously [1]. Without a doubt, prostate and rectal cancers are more likely to present metachronously, with prior radiotherapy for prostate cancer being the main proposed link [2]. Despite the significant advances in radiotherapy administration techniques, it is believed, although still of clinical controversy, that previous external beam radiotherapy for prostate cancer predisposes to the development of rectal cancer, as the rectum, most specifically the anterior rectum, receives a dose of the radiotherapy beam [3, 4]. The relevant interaction is more blur when it comes to prostate brachytherapy [5, 6]; however, it must be mentioned that the conflicting findings regarding the impact of prostate radiotherapy in future rectal cancer development could be explained by the fact that the mutagenic effects of radiotherapy are accumulative in nature and therefore studies with long-term follow-up are needed to establish any possible associations.

As the majority of men will develop at some age prostate neoplasias and taking into account the high prevalence of rectal cancer, despite the implementation of screening protocols and the advances in terms of primary prevention for both of these malignancies, it would be not endangered to claim that the scenario of synchronous prostate and rectal cancer will be increasingly frequent. Moreover, considering the anatomic proximity of the prostate and the rectum, which enables a locally advanced cancer to invade in tissue continuity the other, it is evident that the accurate diagnostic work-up and treatment strategy requires a multidisciplinary approach, in order to optimize the standards of the care delivered and maintain the patient’s quality of life. Herein, our aim is to provide a comprehensive review of the published literature regarding the management of the, not as infrequent as believed to be, challenging scenario of synchronous prostate and rectal cancer in a framework of a patient-centered multidisciplinary approach.

We performed a comprehensive review of the published literature in PubMed database, using “prostate cancer”, “rectal cancer”, “synchronous”, “simultaneous” and their combinations as key phrases. Studies published in other than the English language were not included in our review. The review of the literature was performed independently by two of the contributing authors (CS and NL).

Our literature search yielded eight papers which were suitable to the purpose of our review [7-14]; three were case reports and the remaining five referred to case series, describing a total of 23 cases with synchronous prostate and rectal cancers. In a general overview, the vast majority of patients presented with symptoms suggestive of a colorectal lesion and in the sequential diagnostic work-up, the suspicion of a concurrent prostate malignancy occurred as a result of an abnormal digital rectal examination or elevated PSA titer, fact which led to further imaging of the pelvis and if appropriate the performance of biopsies of the prostate gland. However, in one of the included studies [12], the authors performed a prospective screening assessment for prostate cancer in a group of 20 patients who were scheduled to undergo an abdominoperineal resection for rectal cancer, detecting a rectal cancerous lesion in three out of the 20 cases.

In terms of the most preferred surgical intervention with curative intent, 8/23 patients underwent radical retropubic prostatectomy and abdominoperineal excision or low anterior resection depending on the tumor location, while 2/23 were submitted to pelvic exenteration with formation of ileal or colonic conduit respectively. Another option adopted was the utilization of chemoradiotherapy with or without androgen deprivation therapy aiming to achieve maximal regression primarily of the prostate cancer, followed by either low anterior or abdominoperineal resection for the remaining rectal tumor (4/23 cases).

The patients’ demographics, presenting features, histological characteristics of the prostate and rectal cancers, as well as the treatment strategies followed on each occasion and the outcome of the interventions were retrieved and are presented in a detailed manner in Tables 1 and 2.

Click to view

Table 1. Presentation of Patients’ Demographics, Presenting Features, Histological Characteristics of the Prostate and Rectal Cancers, as Well as the Treatment Strategies Followed on Each Occasion and the Outcome of the Interventions

Click to view

Table 2. Presentation of Patients’ Demographics, Presenting Features, Histological Characteristics of the Prostate and Rectal Cancers, as Well as the Treatment Strategies Followed on Each Occasion and the Outcome of the Interventions

Despite being an uncommon co-incidental finding, the existence of synchronous prostate and rectal cancer will be a clinical problem that will be encountered more frequently due to the increase in life expectancy, since they still remain two of the most frequent malignancies in the male population. Taking into consideration the complexity of a surgical intervention with a curative intent and the high likelihood to perform extended resections without being able to preserve the autonomic function, it is essential that careful preoperative planning and thorough discussion with the patients is performed, explaining the balance between optimal oncological surgery and preservation of the functional anatomy with better the quality of life with tissue sparing surgery. Moreover, the existence of multiple options in terms of neoadjuvant and adjuvant therapies may enable effective local control at least of one of the two primary tumors and sequentially be followed by a more oncologically feasible operation.

Conflict of Interest

The authors have no competing interests to declare.

1. Nash GF, Turner KJ, Hickish T, Smith J, Chand M, Moran BJ. Interactions in the aetiology, presentation and management of synchronous and metachronous adenocarcinoma of the prostate and rectum. Ann R Coll Surg Engl. 2012;94(7):456-462.
   pubmed
2. Margel D, Baniel J, Wasserberg N, Bar-Chana M, Yossepowitch O. Radiation therapy for prostate cancer increases the risk of subsequent rectal cancer. Ann Surg. 2011;254(6):947-950.
   pubmed
3. Kendal WS, Eapen L, Macrae R, Malone S, Nicholas G. Prostatic irradiation is not associated with any measurable increase in the risk of subsequent rectal cancer. Int J Radiat Oncol Biol Phys. 2006;65(3):661-668.
   pubmed
4. Zelefsky MJ, Housman DM, Pei X, Alicikus Z, Magsanoc JM, Dauer LT, St Germain J, et al. Incidence of secondary cancer development after high-dose intensity-modulated radiotherapy and image-guided brachytherapy for the treatment of localized prostate cancer. Int J Radiat Oncol Biol Phys. 2012;83(3):953-959.
   pubmed
5. Hinnen KA, Schaapveld M, van Vulpen M, Battermann JJ, van der Poel H, van Oort IM, van Roermund JG, et al. Prostate brachytherapy and second primary cancer risk: a competitive risk analysis. J Clin Oncol. 2011;29(34):4510-4515.
   pubmed
6. Huo D, Hetzel JT, Roy H, Rubin DT. Association of colorectal cancer and prostate cancer and impact of radiation therapy. Cancer Epidemiol Biomarkers Prev. 2009;18(7):1979-1985.
   pubmed
7. Klee LW, Grmoljez P. Combined radical retropubic prostatectomy and rectal resection. Urology. 1999;54(4):679-681.
   pubmed
8. Siu W, Kapp DS, Wren SM, King C, Terris MK. External beam radiotherapy for synchronous rectal and prostatic tumors. Urology. 2001;57(4):800.
   pubmed
9. Lin C, Jin K, Hua H, Lin J, Zheng S, Teng L. Synchronous primary carcinomas of the rectum and prostate: Report of three cases. Oncol Lett. 2011;2(5):817-819.
   pubmed
10. Ayhan S, Ozdamar A, Nese N, Aydede H. The synchronous primary carcinomas of the rectum and prostate. Indian J Pathol Microbiol. 2011;54(4):800-802.
    pubmed
11. Ozsoy O, Fioretta G, Ares C, Miralbell R. Incidental detection of synchronous primary tumours during staging workup for prostate cancer. Swiss Med Wkly. 2010;140(15-16):233-236.
    pubmed
12. Kavanagh DO, Quinlan DM, Armstrong JG, Hyland JM, O'Connell PR, Winter DC. Management of synchronous rectal and prostate cancer. Int J Colorectal Dis. 2012;27(11):1501-1508.
    pubmed
13. Terris MK, Wren SM. Results of a screening program for prostate cancer in patients scheduled for abdominoperineal resection for colorectal pathologic findings. Urology. 2001;57(5):943-945.
    pubmed
14. Colonias A, Farinash L, Miller L, Jones S, Medich DS, Greenberg L, Miller R, et al. Multidisciplinary treatment of synchronous primary rectal and prostate cancers. Nat Clin Pract Oncol. 2005;2(5):271-274, quiz 271 p following 274.
    pubmed

This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Journal of Clinical Medicine Research is published by Elmer Press Inc.